Back to top
more

Oppenheimer Global Opportunities A: (MF: OPGIX)

(MF) As of Jan 13, 2017 06:05 PM ET

 Add to portfolio

$47.59 USD

+0.30 (0.63%)

Zacks MF Rank [?]: 1-Strong Buy 1        

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Latest Performance as of Dec 31, 2016

Total Return %* Percentile Rank Objective
YTD 10.70 16
3 months -2.23 70
6 months 11.47 11
1 Year 10.70 16
3 Year 6.78 4
5 Year 13.57 11
10 Year 7.40 2

* Annual for three years and beyond.

Zacks Premium Research for OPGIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Strong Buy 1
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 28.08
% Yield 0.24
% SEC Yield NA
Net Assets (Mil $) 12/31/2016 2,425.59
%Turnover 12/31/2016 26.00

Risk

3 Year 5 Year 10 Year
Beta 1.13 1.16 1.16
Alpha -2.18 -2.39 0.41
R Squared 0.50 0.55 0.74
Std. Dev. 17.19 16.21 20.78
Sharpe 0.48 0.92 3.00

Sector / Country Weightings

As of 12/31/2016 % of Portfolio
United States 58.84
Other 10.90
United Kingdom 9.12
Germany 5.64
Japan 5.42
Denmark 5.35
France 1.97
Sweden 1.22
Belgium 0.54
Italy 0.48

Portfolio Holdings

Top Equity Holdings
(As of 9/30/2016)
% of Portfolio Value (Mil$)
NEKTAR THERAPEUTICS 11.23 429.50
ADVANCED MICRO DEVICES IN 5.06 193.48
GENMAB AS 2.69 102.82
COHERENT INC 2.60 99.49
SEATTLE GENETICS INC 1.98 75.61
PANDORA AS 1.90 72.75
SO-NET M3 INC 1.78 68.11
NOVOZYMES 1.73 65.97
H LUNDBECK AS 1.72 65.69

Stock Holding % of Net Assets

As Of 9/30/2016
Total Issues NA
Avg. P/E 24.77
Avg. P/Book 5.10
Avg. EPS Growth 2.73
Avg. Market Value (Mil $) 9,872

Allocation

% of Portfolio
Large Growth 8.36
Large Value 0.00
Small Growth 24.86
Small Value 0.00
Foreign Stock 12.72
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 24.00
High Yield Bond 0.00